注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Cytosorbents Corp是一家專注於重症監護的免疫治療公司。該公司通過聚合物吸附技術進行血液淨化,從事重症監護(ICU)和心臟手術中危及生命的疾病的治療。該公司的主導產品CytoSorb是一種體外細胞因子吸收劑,旨在減少細胞因子風暴或細胞因子釋放綜合徵,否則可能導致大量炎症、器官衰竭和常見危重疾病死亡,如敗血症、燒傷、創傷、肺損傷、癌症免疫治療和胰腺炎引起的細胞因子釋放綜合徵。其其他產品包括動物靶向VetResQ、DrugSorb ATR和ECOS-300CY。該公司正在開發的候選產品包括CytoSorb XL、BetaSorb、Contrast Sorb、DrugSorb、HemoDefense RBC、HemoDefense BGA、K+Control,以及其他包含吸附劑和多孔聚合物珠的藥筒。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Carl H. June | 69 | 2017 | Member of Scientific Advisory Board |
Jiny Kim | 46 | 2022 | Independent Director |
Peter Wearden | - | - | Member of Cardiac Surgery Advisory Board |
Phillip P. Chan | 53 | 2008 | CEO & Director |
Mitchell Cohen | - | - | Member of Trauma Advisory Board |
Ernest E. Moore | - | 2013 | Member of Trauma Advisory Board |
Michael G. Bator | 59 | 2015 | Independent Chairman of the Board |
Craig R. Smith | - | - | Member of Cardiac Surgery Advisory Board |
Joseph Zwischenberger | - | 2014 | Chairman of Cardiac Surgery Advisory Board |
Claudio Ronco | - | - | Member of Critical Care Advisory Board |
Alan D. Sobel | 62 | 2014 | Independent Director |
Robert H. Bartlett | 84 | 2009 | Co-Chairman of Cardiac Surgery Advisory Board & Consultant |
Edward R. Jones | 75 | 2007 | Independent Director |
Ronald V. Maier | - | 2013 | Chairman of the Trauma Advisory Board |
Joseph E. Parrillo | - | - | Member of Critical Care Advisory Board |
Jonathan William Haft | - | 2014 | Member of Cardiac Surgery Advisory Board |
Nicholas Smedira | - | 2014 | Member of Cardiac Surgery Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核